chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Chills, Fatigue, Lymphadenopathy, Pyrexia
Clinical narrative: fever; Chills; chest discomfort; fatigue; lymph node swelling; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 46 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 26Jan2022 13:15 (Lot number: FJ5682) at the age of 46 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "known allergies: eggs" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose 1, Lot number: EN6203, Location of injection: Arm left, Route of Administration: Intramuscular), administration date: 21Mar2021, when the patient was 45 years old, for COVID-19 Immunization; Bnt162b2 (Dose 2, Lot number: ER8730, Location of injection: Arm left, Route of Administration: Intramuscular), administration date: 22Apr2021, when the patient was 45 years old, for COVID-19 immunization. The following information was reported: PYREXIA (non-serious) with onset 27Jan2022 06:00, outcome "recovering", described as "fever"; CHILLS (non-serious) with onset 27Jan2022 06:00, outcome "recovering", described as "Chills"; CHEST DISCOMFORT (non-serious) with onset 27Jan2022 06:00, outcome "recovering", described as "chest discomfort"; FATIGUE (non-serious) with onset 27Jan2022 06:00, outcome "recovering", described as "fatigue"; LYMPHADENOPATHY (non-serious) with onset 27Jan2022 06:00, outcome "recovering", described as "lymph node swelling". Therapeutic measures were not taken as a result of pyrexia, chills, chest discomfort, fatigue, lymphadenopathy.  Additional information: The patient did not receive any other medications in two weeks. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The device date was reported as 29Jan2022. The case was assessed as non-serious.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Dizziness, Dyspnoea, Fatigue, Feeling abnormal
Clinical narrative: warm sensation in my chest, upper stomach, lower chest area; I felt real wired. I felt like wired warm sensation in my chest, upper stomach, lower chest area; I have been feeling funny from the past Saturday; Dizzy; Fatigue; normal chills; body ache; headache; Shortness of breath; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 24Jan2022 (Lot number: FJ1614) as dose 1, single for covid-19 immunisation. Relevant medical history included: "had covid previously" (unspecified if ongoing), notes: had covid previously. The patient's concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious) with onset 24Jan2022, outcome "unknown", described as "I felt real wired. I felt like wired warm sensation in my chest, upper stomach, lower chest area; I have been feeling funny from the past Saturday"; DYSPNOEA (non-serious) with onset Jan2022, outcome "unknown", described as "Shortness of breath"; DIZZINESS (non-serious) with onset 24Jan2022, outcome "unknown", described as "Dizzy"; FATIGUE (non-serious) with onset Jan2022, outcome "unknown", described as "Fatigue"; CHILLS (non-serious) with onset Jan2022, outcome "unknown", described as "normal chills"; PAIN (non-serious) with onset Jan2022, outcome "unknown", described as "body ache"; HEADACHE (non-serious) with onset Jan2022, outcome "unknown", described as "headache"; FEELING HOT (non-serious), outcome "unknown", described as "warm sensation in my chest, upper stomach, lower chest area".  Follow-up attempts completed. No further information expected.
Sex: U
Vaccine: COVID19
Symptoms: Feeling hot, Headache, Pain
Clinical narrative: warm sensation in my chest, upper stomach, lower chest area; I felt real wired. I felt like wired warm sensation in my chest, upper stomach, lower chest area; I have been feeling funny from the past Saturday; Dizzy; Fatigue; normal chills; body ache; headache; Shortness of breath; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 24Jan2022 (Lot number: FJ1614) as dose 1, single for covid-19 immunisation. Relevant medical history included: "had covid previously" (unspecified if ongoing), notes: had covid previously. The patient's concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious) with onset 24Jan2022, outcome "unknown", described as "I felt real wired. I felt like wired warm sensation in my chest, upper stomach, lower chest area; I have been feeling funny from the past Saturday"; DYSPNOEA (non-serious) with onset Jan2022, outcome "unknown", described as "Shortness of breath"; DIZZINESS (non-serious) with onset 24Jan2022, outcome "unknown", described as "Dizzy"; FATIGUE (non-serious) with onset Jan2022, outcome "unknown", described as "Fatigue"; CHILLS (non-serious) with onset Jan2022, outcome "unknown", described as "normal chills"; PAIN (non-serious) with onset Jan2022, outcome "unknown", described as "body ache"; HEADACHE (non-serious) with onset Jan2022, outcome "unknown", described as "headache"; FEELING HOT (non-serious), outcome "unknown", described as "warm sensation in my chest, upper stomach, lower chest area".  Follow-up attempts completed. No further information expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Itching all over body with rash; Itching all over body with rash; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 38 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 26Jan2022 11:30 (Lot number: 331308A) at the age of 38 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Depression" (unspecified if ongoing); "Anxiety" (unspecified if ongoing). Concomitant medication(s) included: VISTARIL [HYDROXYZINE EMBONATE]; EFFEXOR. Past drug history included: Known allergies: zithromax, reaction(s): "known allergies: Zithromax"; Known allergies: benadryl creams, reaction(s): "known allergies: Benadryl creams", notes: known allergies: Benadryl creams. The following information was reported: PRURITUS (non-serious), RASH (non-serious) all with onset 26Jan2022 21:30, outcome "not recovered" and all described as "Itching all over body with rash". Therapeutic measures were not taken as a result of pruritus, rash.  Additional information: The patient had not received any other vaccine within four week prior to vaccination. Prior to vaccination the patient was not diagnosed with Covid-19. Since vaccination the patient was not tested for Covid-19. These adverse events did not result in emergency room/physician visit.  No follow-up attempts are possible. No further information is expected.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Influenza, Product administered to patient of inappropriate age, Pyrexia
Clinical narrative: Bad flue symptoms; Fever of 102.5; patient is 11 years old; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 11 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 30Jan2022 09:30 (Lot number: FL0007) at the age of 11 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Past drug history included: No, notes: No. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: FK5618, Location of injection: Arm Left, Vaccine Administration Time: 08:45 AM), administration date: 08Jan2022, when the patient was 11 years old, for COVID-19 immunization, reaction(s): "felt light headed", "had pain in her upper back", "Nausea", "severe headache", "fever of 102.5". The following information was reported: INFLUENZA (non-serious) with onset 30Jan2022 17:00, outcome "not recovered", described as "Bad flue symptoms"; PYREXIA (non-serious) with onset 30Jan2022 17:00, outcome "not recovered", described as "Fever of 102.5"; PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (non-serious) with onset 30Jan2022 09:30, outcome "not recovered", described as "patient is 11 years old". The events "bad flue symptoms", "fever of 102.5" and "patient is 11 years old" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of influenza, pyrexia, product administered to patient of inappropriate age.  Additional information: Did the patient receive any other vaccines within 4 weeks prior to the COVID vaccine: no and Prior to vaccination, was the patient diagnosed with COVID-19 was no Since the vaccination, has the patient been tested for COVID-19 was no.   No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: fever on and off; I''ve been having a low grade and a high grade fever; it''s been more than 24 hours that I''ve had fever; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Lot number: FL3197) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 immunization. The following information was reported: PYREXIA (non-serious), outcome "not recovered", described as "fever on and off; I''ve been having a low grade and a high grade fever; it''s been more than 24 hours that I''ve had fever". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: It was stated, Basically patient was just concerned about that have been having a fever on and off since patient got 2nd dose of Pfizer. Patient got it on Thursday and then started feeling fever around 10 O' Clock that night and patient have been having a low grade and a high grade fever like ever since then. It was stated, Yeah, patient just wanted to know was it normal that it was been going on for now like more patient would say more than a day because it was been more than 24 hours that have had fever.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Pain in extremity, Tremor, Urticaria
Clinical narrative: chills with violent shaking; chills with violent shaking; arm stayed sore; several large welts on my left arm.; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult patient received bnt162b2 (BNT162B2), administered in arm left, administration date 16Jan2022 (Lot number: 33036BD) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EW0176, Location of injection: Arm Left), administration date: 16May2021, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EW0176, Location of injection: Arm Left), administration date: 25Apr2021, for COVID-19 immunization. The following information was reported: CHILLS (non-serious), TREMOR (non-serious) all with onset 16Jan2022, outcome "recovered" and all described as "chills with violent shaking"; PAIN IN EXTREMITY (non-serious) with onset 16Jan2022, outcome "recovered", described as "arm stayed sore"; URTICARIA (non-serious) with onset 16Jan2022, outcome "recovered", described as "several large welts on my left arm.". Therapeutic measures were not taken as a result of chills, tremor, pain in extremity, urticaria.  Additional information: Patient got the booster Sunday morning. By bedtime, had chills with violent shaking. Patient arm stayed sore for several days, and by Wednesday, there were several large welts on my left arm. No other vaccine in four weeks. Other medications in two weeks: multivitamin. No COVID prior vaccination. No COVID tested post vaccination. No known allergies.   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Asthma
Clinical narrative: asthma; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Manufacturer unknown), for Covid-19 immunization. The following information was reported: ASTHMA (non-serious), outcome "unknown", described as "asthma".  Additional information: Consumer says she is calling to ask questions about severe side effects, and she had reaction from the booster shot and wants information about them. Caller declines to complete a report and says she wants information first, information about severe side effects to the booster. Caller is unable to specify which Pfizer vaccine she got a booster too. Caller says she has asthma.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Illness
Clinical narrative: she also got really sick; Lost her taste and smell; Lost her taste and smell; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "she also got really sick"; ANOSMIA (non-serious), AGEUSIA (non-serious), outcome "unknown" and all described as "Lost her taste and smell".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 6.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Body temperature, Diarrhoea, Headache, Lethargy
Clinical narrative: vomiting; Fever (high = 101.9) the day after; stomach ache; headache; lethargy; diarrhea; This is a spontaneous report received from a contactable reporter(s) (Pharmacist).  A 6 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in leg left, administration date 27Jan2022 (Lot number: FL0007) at the age of 6 years as dose 2, 10 ug single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: FK5618, Location of injection: Leg Left, Route of Administration: Intramuscular), administration date: 05Jan2022, when the patient was 6 years old, for COVID-19 Immunization. The following information was reported: VOMITING (non-serious) with onset 28Jan2022, outcome "recovering", described as "vomiting"; PYREXIA (non-serious) with onset 28Jan2022, outcome "recovering", described as "Fever (high = 101.9) the day after"; ABDOMINAL PAIN UPPER (non-serious) with onset 28Jan2022, outcome "recovering", described as "stomach ache"; HEADACHE (non-serious) with onset 28Jan2022, outcome "recovering", described as "headache"; LETHARGY (non-serious) with onset 28Jan2022, outcome "recovering", described as "lethargy"; DIARRHOEA (non-serious) with onset 28Jan2022, outcome "recovering", described as "diarrhea". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of vomiting, pyrexia, abdominal pain upper, headache, lethargy, diarrhoea.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient does not receive any other medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 6.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: vomiting; Fever (high = 101.9) the day after; stomach ache; headache; lethargy; diarrhea; This is a spontaneous report received from a contactable reporter(s) (Pharmacist).  A 6 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in leg left, administration date 27Jan2022 (Lot number: FL0007) at the age of 6 years as dose 2, 10 ug single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: FK5618, Location of injection: Leg Left, Route of Administration: Intramuscular), administration date: 05Jan2022, when the patient was 6 years old, for COVID-19 Immunization. The following information was reported: VOMITING (non-serious) with onset 28Jan2022, outcome "recovering", described as "vomiting"; PYREXIA (non-serious) with onset 28Jan2022, outcome "recovering", described as "Fever (high = 101.9) the day after"; ABDOMINAL PAIN UPPER (non-serious) with onset 28Jan2022, outcome "recovering", described as "stomach ache"; HEADACHE (non-serious) with onset 28Jan2022, outcome "recovering", described as "headache"; LETHARGY (non-serious) with onset 28Jan2022, outcome "recovering", described as "lethargy"; DIARRHOEA (non-serious) with onset 28Jan2022, outcome "recovering", described as "diarrhea". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of vomiting, pyrexia, abdominal pain upper, headache, lethargy, diarrhoea.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient does not receive any other medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: I need to ask some questions about adverse allergic reaction; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose: X Manufacture Unknown), for Covid-19 Immunization. The following information was reported: HYPERSENSITIVITY (non-serious), outcome "unknown", described as "I need to ask some questions about adverse allergic reaction".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Headache, SARS-CoV-2 test
Clinical narrative: experienced headaches; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 20220116192 (Janssen).  A female patient received bnt162b2 (BNT162B2), administration date 11Nov2021 (Lot number: THB020) as dose 2 (booster), single for covid-19 immunisation. Relevant medical history included: "Interchange of vaccine products" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Janssen covid-19 vaccine (DOSE 1, SINGLE, batch number: 1808900, 1808980, Suspension for injection), administration date: 09Apr2021, for Prophylactic vaccination. The following information was reported: HEADACHE (non-serious) with onset 07Jan2022, outcome "unknown", described as "experienced headaches". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: No adverse events were reported following administration of covid-19 vaccine (dose number in series 1). On 07Jan2022, the patient experienced headaches (dose number in series 2). On 08Jan2022, Laboratory data included: COVID-19 PCR (polymerase chain reaction) test (NR: not provided) Negative. On 10Jan2022, Laboratory data included: COVID-19 rapid POC (Point of care) test (NR: not provided) Negative. Event abate after stopping drug was Not applicable. Causality as per reporter and as per Mfr. was Possible.   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: tachycardia; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 28 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TACHYCARDIA (non-serious), outcome "unknown", described as "tachycardia".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Malaise, Pain in extremity
Clinical narrative: soreness of arm was after taking the Pfizer first dose; Did not feel good at 3 weeks after receiving the first dose Adult Pfizer Covid 19 Vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date Aug2021 (Batch/Lot number: unknown) as dose 2 (booster), single for covid-19 immunisation. Relevant medical history included: "Type 1 Diabetes" (unspecified if ongoing), notes: She initially have Type 1 Diabetes, making her nervous to get 2 shots of COVID19 Vaccine; "Interchange of vaccine products", start date: Aug2021 (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: J&j vaccine (Dose 1), administration date: 06Apr2021, for Covid-19 immunization, reaction(s): "nauseous for a couple of days and did throw up", "first day the throwing up was self induced". The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Aug2021, outcome "unknown", described as "soreness of arm was after taking the Pfizer first dose"; MALAISE (non-serious) with onset Aug2021, outcome "unknown", described as "Did not feel good at 3 weeks after receiving the first dose Adult Pfizer Covid 19 Vaccine". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: A week later in Aug2021, the patient had her first dose of Pfizer COVID-19 Vaccine. Caller mentioned that there was a small soreness on her arm during the first dose and Did not feel good at 3 weeks after receiving the first dose Adult Pfizer Covid 19 Vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Burning sensation, Eczema
Clinical narrative: extreme eczema; I am on fire; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 71 year-old patient received bnt162b2 (BNT162B2), administration date 25Oct2021 (Batch/Lot number: unknown) as dose 3 (booster),single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, SINGLE; MANUFACTURER UNKNOWN, ), for covid-19 immunization; Covid-19 vaccine (DOSE 2, SINGLE; MANUFACTURER UNKNOWN, ), for Covid-19 Immunization. The following information was reported: ECZEMA (non-serious) with onset Nov2021, outcome "unknown", described as "extreme eczema"; BURNING SENSATION (non-serious) with onset Nov2021, outcome "unknown", described as "I am on fire". Therapeutic measures were taken as a result of eczema, burning sensation.  Additional Information: The patient stated that, I received my Pfizer covid booster vaccine on 25Oct2021. The first week of Nov an extreme eczema outbreak occurred around my mouth and nose. Although there is no history of eczema in my family, and I have never experienced it in my seventy one years, I am on fire with is 24x7. I am being treated at (Clinic name withheld).  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Swelling
Clinical narrative: patient had rash and swelling starting day after vaccination; patient had rash and swelling starting day after vaccination; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP). The reporter is the patient.  A 37 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 37 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RASH (non-serious), SWELLING (non-serious), outcome "unknown" and all described as "patient had rash and swelling starting day after vaccination".  Additional information: Reported Event: patient had rash and swelling starting day after vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: fever of 39C; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): MDIT22-00132 (Moderna).  A 28 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in deltoid right, administration date 14Aug2021 (Lot number: FG4686) at the age of 28 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Administered into the left deltoid muscle. Batch: FE2707.), administration date: 07May2021, when the patient was 28 years old, for Covid-19 Immunization, reaction(s): "moderate muscle pain", "joint pain", "pain and swelling focused at the injection site", "pain and swelling focused at the injection site". The following information was reported: PYREXIA (non-serious) with onset Aug2021, outcome "unknown", described as "fever of 39C". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pyrexia.  Additional information:   No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Swelling, Urticaria
Clinical narrative: Rash; hives with little swelling; hives with little swelling; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP). The reporter is the patient.  A 37 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date Nov2021 (Lot number: 8020t7t) at the age of 37 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Past drug history included: Ib profen, reaction(s): "known allergies: IB Profen". The following information was reported: RASH (non-serious) with onset Dec2021, outcome "recovered", described as "Rash"; URTICARIA (non-serious), SWELLING (non-serious) all with onset Dec2021, outcome "recovered" and all described as "hives with little swelling". Therapeutic measures were not taken as a result of rash, urticaria, swelling.  Additional information: Patient not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient not received any other medications within 2 weeks of vaccination.    No follow-up attempts are possible. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Pain, Vertigo
Clinical narrative: coughing nonstop; full body pains; Vertigo; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 23 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 01Feb2022 12:15 (Lot number: FL3209) at the age of 23 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Depression" (unspecified if ongoing); "Covid-19" (unspecified if ongoing), notes: If covid prior vaccination: Yes. Concomitant medication(s) included: ZOLOFT; JUNEL. Vaccination history included: Bnt162b2 (Dose 2, single, lot number=EW0191,, dose administrator route=Intramuscular,, vaccine location=Right arm), administration date: 16Jun2021, when the patient was 22 years old, for Covid-19 immunization; Bnt162b2 (Dose 1, single, lot number=EW0186,, dose administrator route=Intramuscular,, vaccine location=Right arm), administration date: 26May2021, when the patient was 22 years old, for Covid-19 immunization. The following information was reported: COUGH (non-serious) with onset 01Feb2022 22:00, outcome "recovering", described as "coughing nonstop"; PAIN (non-serious) with onset 01Feb2022 22:00, outcome "recovering", described as "full body pains"; VERTIGO (non-serious) with onset 01Feb2022 22:00, outcome "recovering", described as "Vertigo". Therapeutic measures were not taken as a result of cough, pain, vertigo.  Additional Information: The patient has no reported allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. After my booster shot (shot 3) I've been coughing nonstop and having full body pains as well as vertigo.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect route of product administration, Lymphadenopathy, Pain, Swelling
Clinical narrative: ipsilateral supraclavicular lymphadenopathy after covid 19 vaccination; The pain and swelling was excruciating; The pain and swelling was excruciating; The vaccine was given to high in the deltoid; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 55 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in deltoid right, administration date 25Jan2022 10:30 (Lot number: 33036BD) at the age of 55 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Goji Berries allergy" (unspecified if ongoing); "High Cholesterol" (unspecified if ongoing); "Gerd" (unspecified if ongoing); "Migraines" (unspecified if ongoing). Concomitant medication(s) included: LIPITOR. Past drug history included: Flu vaccine, reaction(s): "Allergy". Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: FC3183, Location of injection: Arm Right, Route of Administration: Intramuscular), administration date: 31Aug2021, when the patient was 55 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, at 12:30 PM, Batch/Lot No: FA7485, Location of injection: Arm Right, Route of Administration: Intramuscular), administration date: 10Aug2021, when the patient was 55 years old, for COVID-19 immunization. The following information was reported: INCORRECT ROUTE OF PRODUCT ADMINISTRATION (non-serious) with onset 25Jan2022 10:30, outcome "not recovered", described as "The vaccine was given to high in the deltoid"; LYMPHADENOPATHY (non-serious) with onset 25Jan2022 20:00, outcome "not recovered", described as "ipsilateral supraclavicular lymphadenopathy after covid 19 vaccination"; SWELLING (non-serious), PAIN (non-serious) all with onset 25Jan2022 20:00, outcome "not recovered" and all described as "The pain and swelling was excruciating". The events "the vaccine was given to high in the deltoid", "ipsilateral supraclavicular lymphadenopathy after covid 19 vaccination", "the pain and swelling was excruciating" and "the pain and swelling was excruciating" were evaluated at the emergency room visit. Therapeutic measures were taken as a result of incorrect route of product administration, lymphadenopathy, swelling, pain.  Additional Information: As treatment patient received Toradolim and Muscle Relaxant. Covid was prior vaccination. Covid was not tested post vaccination.  No follow-up attempts are possible. No further information is expected.  Follow-up (07Feb2022): Follow-up attempts are completed. No further information is expected.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Dry mouth, Dry throat, Dysphagia, Urticaria
Clinical narrative: difficulty in swallowing; dry throat is still there; Dry mouth; massive hives; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 18 year-old female patient received bnt162b2 (COMIRNATY), administered in arm left, administration date 30Jan2022 01:00 (Lot number: FK9896) at the age of 18 years as dose 3 (booster), 0.3 ml single for covid-19 immunisation. Relevant medical history included: "Irritable bowel syndrome" (unspecified if ongoing), notes: Verbatim: Irritable bowel syndrome. There were no concomitant medications. Vaccination history included: Comirnaty (Dose 1), for COVID-19 Immunization; Comirnaty (Dose 2), for COVID-19 Immunization. The following information was reported: URTICARIA (non-serious) with onset 30Jan2022 02:00, outcome "not recovered", described as "massive hives"; DYSPHAGIA (non-serious) with onset 31Jan2022, outcome "recovering", described as "difficulty in swallowing"; DRY THROAT (non-serious) with onset 31Jan2022, outcome "not recovered", described as "dry throat is still there"; DRY MOUTH (non-serious) with onset 31Jan2022, outcome "not recovered", described as "Dry mouth". The events "massive hives", "difficulty in swallowing", "dry throat is still there" and "dry mouth" were evaluated at the emergency room visit. Therapeutic measures were taken as a result of urticaria, dysphagia, dry throat, dry mouth.  Additional information: Caller was an 18-year old female who received the 1st, 2nd, and booster dose of Comirnaty. Caller said she was fine with the 1st 2 doses however, with the booster, she had massive hives and experienced difficulty in swallowing. Caller gave lot number FK9896 and wanted to know if this has any relation to the adverse effects she had. Caller added she just called in to report this. The caller is calling about the Pfizer booster, the third dose of the Pfizer covid vaccine. The caller wants to report a side effect she experienced. The caller received all 3 doses by Pfizer and was fine with the first two doses. With the third dose the caller had massive hives and difficulty swallowing, but no chest pain or problems breathing. Has the same lot had other complications. 1 hour after the caller received the vaccine the hives started, at 2:00. The caller is on steroids and other medications and has been to 2 emergency departments. The caller was never admitted as a patient because it got better with the stuff she was taking but now it keeps coming back. The difficulty swallowing is getting better but the dry throat is still there.  No follow-up attempts are possible. No further information is expected.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site reaction
Clinical narrative: left arm, at the injection site, has not stopped itching; left arm, at the injection site, has not stopped itching; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 11Oct2021 16:00 (Batch/Lot number: unknown) at the age of 70 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Known allergies: Raw egg" (unspecified if ongoing), notes: Known allergies: Raw egg. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 2, Single, Previous dose details:, Prev dose product: COVID 19, Prev dose brand: Pfizer, Prev dose brand unknown: False, Prev dose lot unknown: True, Prev dose lot unknown reason: Not available/provided to reporter at the time of report completion, Prev dose administration date: 05Apr2021, Prev dose administration time: 06:00 PM, Prev dose dose number: 2, Prev dose vaccine location: Left arm), administration date: 05Apr2021, when the patient was 69 years old, for Covid-19 Immunization, reaction(s): "Inappropriate schedule of vaccine administered"; Bnt162b2 (DOSE 1, Single, Prev dose product: COVID 19, Prev dose brand: Pfizer, Prev dose brand unknown: False, Prev dose lot unknown: True, Prev dose lot unknown reason: Not available/provided to reporter at the time of report completion, Prev dose administration date: 06Apr2021, Prev dose administration time: 06:00 PM, Prev dose dose number: 1, Prev dose vaccine location: Left arm), administration date: 06Apr2021, when the patient was 69 years old, for Covid-19 Immunization.  The following information was reported: VACCINATION SITE REACTION (non-serious), PRURITUS (non-serious), outcome "not recovered" and all described as "left arm, at the injection site, has not stopped itching". Therapeutic measures were not taken as a result of vaccination site reaction, pruritus.  Additional information: No other vaccine in four weeks. Patient reported that left arm, at the injection site, has not stopped itching. This is now 4 months post vaccination with no relief. No covid prior vaccination. Post vaccination, the patient was not tested for covid. No other medical history reported. The patient reported that he had reaction to the Covid booster and his family physician was confused with him and was not sure.  Follow-up attempts are completed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dyspnoea, Heart rate, Heart rate increased, Pyrexia
Clinical narrative: 105-120 resting heart rate (normally low 70s); Shortness of breath; fever of 101.5 degrees Fahrenheit  (reached 103.5 highest); This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 23 year-old female patient received bnt162b2 (BNT162B2), administration date 2022 (Batch/Lot number: unknown) at the age of 23 years as dose 3 (booster), single for covid-19 immunization. Relevant medical history included: "COVID" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 2. single, Batch/Lot No: Unknown), for COVID-19 immunization; Bnt162b2 (Dose 1, single, Batch/Lot No: Unknown), for COVID-19 immunization. The following information was reported: HEART RATE INCREASED (non-serious) with onset 01Feb2022, outcome "unknown", described as "105-120 resting heart rate (normally low 70s)"; DYSPNOEA (non-serious) with onset 01Feb2022, outcome "unknown", described as "Shortness of breath"; PYREXIA (non-serious) with onset 01Feb2022, outcome "unknown", described as "fever of 101.5 degrees Fahrenheit  (reached 103.5 highest)". The events "105-120 resting heart rate (normally low 70s)", "shortness of breath" and "fever of 101.5 degrees Fahrenheit  (reached 103.5 highest)" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: patient experienced Shortness of breath, 105-120 resting heart rate (normally low 70s), fever of 101.5 (reached 103.5 highest), at 21 hours post-booster shot. Patient was diagnosed with COVID-19 Prior to vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Biopsy, Computerised tomogram thorax, Inflammation, Lymphadenopathy
Clinical narrative: Inflammation is painful as both armpits have swelled; Long-term (9 months and counting) lymphadenopathy in both armpits close to injection sites; Inflammation is painful as both armpits have swelled; Inflammation is painful as both armpits have swelled; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 17Apr2021 11:00 (Lot number: EW0169) at the age of 33 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications.  The following information was reported: AXILLARY PAIN (non-serious), INFLAMMATION (non-serious), SWELLING (non-serious) all with onset 24Apr2021 12:00, outcome "not recovered" and all described as "Inflammation is painful as both armpits have swelled"; LYMPHADENOPATHY (non-serious) with onset 24Apr2021 12:00, outcome "not recovered", described as "Long-term (9 months and counting) lymphadenopathy in both armpits close to injection sites". The events "inflammation is painful as both armpits have swelled", "long-term (9 months and counting) lymphadenopathy in both armpits close to injection sites", "inflammation is painful as both armpits have swelled" and "inflammation is painful as both armpits have swelled" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of axillary pain, lymphadenopathy, inflammation, swelling.  Additional Information: The case was not serious. At Doctor's office or urgent care facility where the most recent COVID-19 vaccine was administered. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There was no other medications the patient received within 2 weeks of vaccination. The lots of diagnostic testing were done but no treatment received. The prior vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling, Ultrasound scan
Clinical narrative: Inflammation is painful as both armpits have swelled; Long-term (9 months and counting) lymphadenopathy in both armpits close to injection sites; Inflammation is painful as both armpits have swelled; Inflammation is painful as both armpits have swelled; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 17Apr2021 11:00 (Lot number: EW0169) at the age of 33 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications.  The following information was reported: AXILLARY PAIN (non-serious), INFLAMMATION (non-serious), SWELLING (non-serious) all with onset 24Apr2021 12:00, outcome "not recovered" and all described as "Inflammation is painful as both armpits have swelled"; LYMPHADENOPATHY (non-serious) with onset 24Apr2021 12:00, outcome "not recovered", described as "Long-term (9 months and counting) lymphadenopathy in both armpits close to injection sites". The events "inflammation is painful as both armpits have swelled", "long-term (9 months and counting) lymphadenopathy in both armpits close to injection sites", "inflammation is painful as both armpits have swelled" and "inflammation is painful as both armpits have swelled" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of axillary pain, lymphadenopathy, inflammation, swelling.  Additional Information: The case was not serious. At Doctor's office or urgent care facility where the most recent COVID-19 vaccine was administered. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There was no other medications the patient received within 2 weeks of vaccination. The lots of diagnostic testing were done but no treatment received. The prior vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Bone pain, Breast swelling, Feeling abnormal, Pain
Clinical narrative: soreness in my arm, bone in my under arm; soreness in my arm, bone in my under arm; right side of my breast is swollen; body ache; Fever; I just don''t feel good; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46 year-old female patient received bnt162b2 (BNT162B2), administered in deltoid right, administration date 31Jan2022 (Lot number: FH8027) at the age of 46 years as dose number unknown (booster), single for covid-19 immunisation. Relevant medical history included: "Polycystic disease" (unspecified if ongoing), notes: Verbatim: polycystic disease; "Hypertension" (unspecified if ongoing), notes: Verbatim: Hypertension; "Blood pressure" (unspecified if ongoing), notes: Verbatim: Blood pressure. Concomitant medication(s) included: NORVASC taken for blood pressure measurement; LOZOL taken for blood pressure measurement; HCTZ taken for blood pressure measurement. Vaccination history included: Covid-19 vaccine (Manufacturer Unknown, Dose number : Unknown), for COVID-19 Immunization. The following information was reported: PAIN IN EXTREMITY (non-serious), BONE PAIN (non-serious) all with onset 2022, outcome "unknown" and all described as "soreness in my arm, bone in my under arm"; BREAST SWELLING (non-serious) with onset 2022, outcome "unknown", described as "right side of my breast is swollen"; PAIN (non-serious) with onset 2022, outcome "unknown", described as "body ache"; PYREXIA (non-serious) with onset 2022, outcome "unknown", described as "Fever"; FEELING ABNORMAL (non-serious) with onset 2022, outcome "unknown", described as "I just don''t feel good". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pain in extremity, bone pain, breast swelling, pain, pyrexia, feeling abnormal.  Additional Information: It was reported that the patient took the Pfizer booster on Monday, was having like soreness in her arm, bone in her under arm, right side of her breast was swollen, she was having body ache, she was having fever,she just didn't feel good. It was further reported that she just had her blood work done. she got the blood work done, everything was fine. They did the PCR testing and it was negative, she was fine beside those things. she had Tylenol, she was taking, every 6 hours. There was no Prior vaccination.    No follow-up attempts are possible. No further information is expected.